ADMIRE-CD Phase 3 trial

October 10, 2017October 10, 2017

TiGenix Presents Positive Results of Potential Crohn’s Therapy, Announces Phase 3 Study

News

TiGenix will present positive results of Cx601 to treat complex perianal fistulas in Crohn’s disease patients at the upcoming World Congress of Gastroenterology ACG 2017 meeting in Orlando, Florida. The company will discuss ... Read more

June 16, 2017June 16, 2017

TiGenix Starts Global Phase 3 Trial to Evaluate Cx601 as a Treatment for Crohn’s Fistulas

News

TiGenix has started a pivotal Phase 3 clinical trial of Cx601’s ability to treat a complication of Crohn’s disease known as complex perianal fistulas. Fistulas are sores between the end of the bowel ... Read more

August 5, 2016August 5, 2016

Stem Cell Therapy for Perianal Fistulas in Crohn’s Patients Shows Benefits in Phase 3 Trial

IBD News

The 24-week results of a Phase 3 trial showing the effectiveness of the investigational therapy Cx601 in the treatment of complex perianal fistulas in patients with Crohn’s disease were recently published in The ... Read more